Cooper Companies, Inc.

NYSE:COO  
380.00
+3.11 (+0.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.82B
Current PE78.94
Forward PE 30.25
2yr Forward PE 26.99
See more stats
Estimates Current Quarter
Revenue$656.37 Million
Adjusted EPS$2.77
See more estimates
10-Day MA$376.24
50-Day MA$351.47
200-Day MA$320.64
See more pivots

COOPER COMPANIES INC Stock, NYSE:COO

6140 STONERIDGE MALL RD, STE 590, PLEASANTON, CA 94588
United States of America
Phone: 9254603600
Number of Employees: 12000

Description

The Cooper Companies, Inc. operates as a medical device company worldwide. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides medical devices, surgical instruments, accessories, and diagnostic products and services for health care professionals and institutions focusing on women's health, fertility, and genetic testing in hospitals, clinician's offices, and fertility clinics. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.